| 4.18 Data as of May 17 |  +0.41 / +10.88%Today’s Change | 1.43 Today|||52-Week Range 4.94 | +104.90% Year-to-Date |
| SECTOR Health Technology | INDUSTRY Biotechnology | MARKET CAP $82.7M |
Company Description
EDAP TMS SA develops, produces, and markets minimally invasive medical devices, mainly for urological diseases. It operates through the High Intensity Focused Ultrasound (HIFU) and Urological Devices and Services (UDS) divisions. The HIFU division is engaged in the development, manufacturing, and marketing of medical devices based on HIFU technology for the minimally invasive treatment of urological and other clinical indications. The UDS division is engaged in the development, marketing, manufacturing, and servicing of medical devices for the minimally invasive diagnosis or treatment of urological disorders, mainly urinary stones and other clinical indications. The company was founded on December 3, 1979 and is headquartered in Vaulx-en-Velin, France
Employees
Shareholders
| Mutual fund holders | 15.38% |
| Other institutional | 11.36% |
| Individual stakeholders | -- |
Top Executives
| Marc Oczachowski | Chief Executive Officer |
| Eric Soyer, MBA | Chief Financial Officer |
| Emmanuel Blanc | Director-Research & Vice President |
| Nasri Benzahia | Sales Manager-United Kingdom |
| Paolo dos Santos | Area Sales Manager-Spain, Portugal & Latin America |
.
